PARD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.647400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.995200E-01
Normal-vs-Stage2
6.170400E-01
Normal-vs-Stage3
9.521200E-01
Normal-vs-Stage4
3.795200E-01
Stage1-vs-Stage2
6.314600E-01
Stage1-vs-Stage3
9.409400E-01
Stage1-vs-Stage4
2.779800E-01
Stage2-vs-Stage3
6.315600E-01
Stage2-vs-Stage4
4.242800E-01
Stage3-vs-Stage4
2.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.894400E-01
Normal-vs-AfricanAmerican
5.447000E-01
Normal-vs-Asian
6.118400E-01
Caucasian-vs-AfricanAmerican
6.808400E-01
Caucasian-vs-Asian
7.001000E-01
AfricanAmerican-vs-Asian
9.144800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.847400E-01
Normal-vs-Female
8.014600E-01
Male-vs-Female
1.244830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.496200E-01
Normal-vs-Age(41-60Yrs)
4.724200E-01
Normal-vs-Age(61-80Yrs)
7.513600E-01
Normal-vs-Age(81-100Yrs)
7.933000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.952400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.648800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.250600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.512000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.370000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.297400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.705200E-01
Normal-vs-Daily Drinker
9.128600E-01
Normal-vs-Weekly Drinker
7.451200E-01
Normal-vs-Occasional Drinker
5.222600E-01
Normal-vs-Social Drinker
5.754800E-01
Non Drinker-vs-Daily Drinker
1.610960E-01
Non Drinker-vs-Weekly Drinker
3.464000E-01
Non Drinker-vs-Occasional Drinker
4.737200E-01
Non Drinker-vs-Social Drinker
7.095800E-01
Daily Drinker-vs-Weekly Drinker
6.378200E-01
Daily Drinker-vs-Occasional Drinker
3.065600E-01
Daily Drinker-vs-Social Drinker
2.947200E-01
Weekly Drinker-vs-Occasional Drinker
6.752800E-01
Weekly Drinker-vs-Social Drinker
5.982800E-01
Occasional Drinker-vs-Social Drinker
8.068400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.183800E-01
Normal-vs-Grade 2
1.630610E-01
Normal-vs-Grade 3
3.956300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.064400E-02
Grade 1-vs-Grade 3
7.596800E-03
Grade 1-vs-Grade 4
3.183800E-01
Grade 2-vs-Grade 3
3.639200E-01
Grade 2-vs-Grade 4
1.630610E-01
Grade 3-vs-Grade 4
3.956300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.718200E-01
Normal-vs-NonDiabetic
7.186600E-01
Diabetic-vs-NonDiabetic
4.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.166600E-01
Normal-vs-NoPancreatitis
7.485600E-01
Pancreatitis-vs-NoPancreatitis
6.219800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.520800E-01
Normal-vs-N1
6.457400E-01
N0-vs-N1
4.620600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.353600E-01
Normal-vs-TP53-NonMutant
7.748800E-01
TP53-Mutant-vs-TP53-NonMutant
3.574300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
